T1	Entity 197 248	cystic fibrosis transmembrane conductance regulator
T2	Entity 250 254	CFTR
T3	Entity 333 347	modifier genes
T4	Entity 266 285	severity of disease
T5	Entity 353 371	intestines of Cftr
T6	Entity 422 433	obstruction
T7	Entity 437 465	excessive mucus accumulation
T8	Entity 493 507	meconium ileus
T9	Entity 397 407	Cftrtm1Unc
T10	Entity 512 550	distal intestinal obstruction syndrome
T11	Entity 720 732	inflammation
T12	Entity 740 755	small intestine
T13	Entity 775 782	smaller
R1	other_relation Arg1:T2 Arg2:T1	
#1	AnnotatorNotes R1	equivalent
R2	interacts_with Arg1:T4 Arg2:T3	
R3	participates_in Arg1:T6 Arg2:T5	
R4	participates_in Arg1:T7 Arg2:T5	
T14	Entity 1101 1117	mixed background
T15	Entity 1187 1218	reduced intestinal inflammation
T16	Entity 1282 1300	normal body weight
T17	Entity 1316 1342	reduced mucus accumulation
T18	Entity 1398 1411	gender effect
T19	Entity 1755 1762	D1Mit36
T20	Entity 1796 1803	D9Mit90
T21	Entity 1843 1851	D10Mit14
R5	participates_in Arg1:T14 Arg2:T15	
R6	participates_in Arg1:T14 Arg2:T16	
R7	participates_in Arg1:T14 Arg2:T17	
T22	Entity 1705 1721	milder phenotype
R8	participates_in Arg1:T19 Arg2:T22	
R9	participates_in Arg1:T20 Arg2:T22	
R10	participates_in Arg1:T21 Arg2:T22	
T23	Entity 1916 1931	positive impact
T24	Entity 1876 1892	modifier regions
T25	Entity 1939 1961	inflammatory phenotype
T26	Entity 1978 1993	small intestine
T27	Entity 1998 2013	animal survival
R11	participates_in Arg1:T24 Arg2:T23	
R12	participates_in Arg1:T24 Arg2:T25	
R13	is_part_of Arg1:T25 Arg2:T26	
R14	is_part_of Arg1:T25 Arg2:T27	
